Calcineurin/NN
mutants/NNS
render/VBP
T/NN
lymphocytes/NNS
resistant/JJ
to/TO
cyclosporin/NN
A/NN
./.

The/DT
immunosuppressants/NNS
cyclosporin/NN
A/NN
(/(
CsA/NN
)/)
and/CC
FK506/NN
have/VBP
been/VBN
widely/RB
used/VBN
to/TO
prevent/VB
and/CC
treat/VB
graft/NN
rejection/NN
after/IN
human/JJ
organ/NN
and/CC
tissue/NN
transplantations/NNS
./.
=====
CsA/NN
and/CC
FK506/NN
associate/VBP
with/IN
intracellular/JJ
binding/VBG
proteins/NNS
(/(
i.e./FW
,/,
CsA/NN
with/IN
cyclophilin/NN
A/NN
and/CC
FK506/NN
with/IN
FKBP12/NN
)/)
to/TO
form/VB
protein/drug/NN
complexes/NNS
that/WDT
suppress/VBP
the/DT
immune/JJ
system/NN
by/IN
preventing/VBG
activation/NN
of/IN
T/NN
cells/NNS
in/IN
response/NN
to/TO
antigen/NN
presentation/NN
./.
=====
The/DT
common/JJ
target/NN
of/IN
CsA/NN
and/CC
FK506/NN
is/VBZ
calcineurin/NN
,/,
a/DT
Ca2+/calmodulin-regulated/JJ
,/,
serine/threonine-specific/JJ
protein/NN
phosphatase/NN
that/WDT
regulates/VBZ
the/DT
nuclear/JJ
import/NN
of/IN
a/DT
transcription/NN
factor/NN
,/,
NF-AT/NN
,/,
required/VBN
for/IN
expression/NN
of/IN
T/NN
cell/NN
activation/NN
genes/NNS
./.
=====
In/IN
previous/JJ
studies/NNS
,/,
we/PRP
identified/VBD
calcineurin/NN
mutations/NNS
that/WDT
block/VBP
binding/NN
by/IN
the/DT
cyclophilin/NN
A/CsA/NN
or/CC
FKBP12/FK506/NN
complexes/NNS
and/CC
thereby/RB
render/VBP
yeast/NN
cells/NNS
resistant/JJ
to/TO
the/DT
antifungal/JJ
effects/NNS
of/IN
CsA/NN
or/CC
FK506/NN
./.
=====
In/IN
this/DT
report/NN
,/,
we/PRP
demonstrate/VBP
that/IN
the/DT
corresponding/JJ
mutations/NNS
in/IN
murine/JJ
calcineurin/NN
render/VBP
the/DT
T/NN
cell/NN
receptor/NN
signal/NN
transduction/NN
cascade/NN
CsA/NN
resistant/JJ
in/IN
human/JJ
Jurkat/NN
T/NN
cells/NNS
./.
=====
Our/PRP$
findings/NNS
support/VBP
the/DT
recently/RB
determined/VBN
calcineurin/NN
X-ray/NN
crystal/NN
structure/NN
,/,
provide/VBP
evidence/NN
that/IN
calcineurin/NN
is/VBZ
the/DT
only/RB
CsA-sensitive/JJ
component/NN
limiting/VBG
signaling/NN
from/IN
the/DT
T/NN
cell/NN
receptor/NN
to/TO
the/DT
nucleus/NN
,/,
and/CC
suggest/VBP
a/DT
means/NN
to/TO
render/VB
cells/NNS
and/CC
tissues/NNS
resistant/JJ
to/TO
the/DT
toxic/JJ
side/JJ
effects/NNS
of/IN
CsA/NN
and/CC
FK506/NN
./.